The Conversation (0)
- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Delta 9 Cannabis announced Health Canada provided an amendment to the company’s cannabis production and sale license, allowing the production of bottled cannabis oils.
Delta 9 Cannabis (TSXV:NINE) announced Health Canada provided an amendment to the company’s cannabis production and sale license, allowing the production of bottled cannabis oils.
As quoted in the press release:
The license amendment was issued on April 20, 2018 and is valid until August 30, 2019.
“This is another important step for Delta 9 in preparing for legalization in Canada, but also in working with our partners in Germany, where we have signed an export agreement,” said Delta 9 CEO John Arbuthnot.
Delta 9 announced the signing of a non-binding letter of intent on March 27, 2018 with Global Group Kalapa S.L. and Canpharma GMBH for the exportation of medical cannabis and cannabis oils to Germany. As part of that agreement, Delta 9 agreed to produce cannabis oil, and agreed to become GMP (Good Manufacturing Process) certified.
Source: www.newswire.ca
Outlook Reports
Featured Cannabis Investing News Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES